WA
TMO icon

WP Advisors’s Thermo Fisher Scientific TMO Stock Holding History

WP Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Sell
623
-146
-19% -$79.2K 0.08% 95
2025
Q4 		$445K Sell
769
-249
-24% -$141K 0.11% 79
2025
Q3 		$494K Sell
1,018
-32
-3% -$14.9K 0.13% 80
2025
Q2 		$426K Buy
1,050
+1
+0.1% +$418 0.12% 79
2025
Q1 		$522K Sell
1,049
-50
-5% -$27.1K 0.17% 70
2024
Q4 		$572K Sell
1,099
-33
-3% -$18.1K 0.19% 65
2024
Q3 		$700K Sell
1,132
-232
-17% -$137K 0.26% 62
2024
Q2 		$754K Sell
1,364
-43
-3% -$24.6K 0.24% 63
2024
Q1 		$818K Buy
1,407
+1
+0.1% +$561 0.27% 59
2023
Q4 		$747K Buy
1,406
+21
+2% +$10.2K 0.28% 60
2023
Q3 		$701K Hold
1,385
– – 0.29% 58
2023
Q2 		$722K Buy
1,385
+1
+0.1% +$540 0.29% 56
2023
Q1 		$798K Buy
1,384
+1
+0.1% +$564 0.33% 54
2022
Q4 		$762K Buy
1,383
+1
+0.1% +$530 0.34% 55
2022
Q3 		$701K Buy
1,382
+1
+0.1% +$560 0.32% 57
2022
Q2 		$751K Sell
1,381
-48
-3% -$26.4K 0.33% 58
2022
Q1 		$844K Sell
1,429
-50
-3% -$28.7K 0.35% 54
2021
Q4 		$987K Hold
1,479
– – 0.41% 50
2021
Q3 		$845K Buy
1,479
+1
+0.1% +$549 0.35% 50
2021
Q2 		$746K Buy
1,478
+101
+7% +$47.7K 0.31% 50
2021
Q1 		$629K Buy
1,377
+59
+4% +$28.2K 0.27% 56
2020
Q4 		$614K Buy
1,318
+30
+2% +$14.1K 0.3% 50
2020
Q3 		$569K Buy
+1,288
New +$532K 0.34% 46

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WP Advisors's TMO Position: Q1 2026 in Review

WP Advisors reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $79.2K and leaving 623 shares worth $306K. The position accounts for 0.08% of the portfolio, ranked #95.

WP Advisors first reported a position in TMO in Q3 2020 and has held it in 23 quarters since. The position peaked at $987K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • WP Advisors held 623 shares of Thermo Fisher Scientific worth $306K as of Q1 2026.
  • WP Advisors sold 146 Thermo Fisher Scientific shares in Q1 2026, an estimated $79.2K.
  • Thermo Fisher Scientific made up 0.08% of WP Advisors's portfolio in Q1 2026, its #95 holding.
  • WP Advisors first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 23 quarters since.
  • WP Advisors's Thermo Fisher Scientific position peaked at $987K in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on WP Advisors's 13F filing for Q1 2026, filed 4 May 2026.